Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BIOGEN INC.BIIB · Entity 1675 | Director | June 09, 2026 | June 11, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BIOGEN INC.
Report date June 09, 2026 · Filed June 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 6,634.1 |
Reported balance
After 2026-06-09 transaction · row 1
1 source rowRow 1 · 2026-06-09 · Grant · Acquired 1,505 · Balance 6,634.1 F1: The restricted stock units vest on the earlier of (i) the next annual meeting or (ii) the anniversary of the date of grant of June 9, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock units vest on the earlier of (i) the next annual meeting or (ii) the anniversary of the date of grant of June 9, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 09, 2026 Filed Jun 11, 2026 21:34 UTC | BIOGEN INC. BIIB · Entity 1675 | GrantCommon Stock | 1,505 | $0.00 | $0.00 |
DisclosureSEC source: 0000875045-26-000060 · form4.xml · nonDerivative · entry 1 LANGER SUSAN · CIK 0001982640 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,634.1 F1 · shares: The restricted stock units vest on the earlier of (i) the next annual meeting or (ii) the anniversary of the date of grant of June 9, 2026. Read SEC document |
| June 17, 2025 Filed Jun 18, 2025 20:38 UTC | BIOGEN INC. BIIB · Entity 1675 | GrantCommon Stock | 2,370 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-017758 · form4.xml · nonDerivative · entry 1 LANGER SUSAN · CIK 0001982640 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,129.1 Read SEC document |
| June 21, 2024 Filed Jun 25, 2024 21:16 UTC | BIOGEN INC. BIIB · Entity 1675 | GrantCommon Stock | 1,340 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-24-019237 · form4.xml · nonDerivative · entry 1 LANGER SUSAN · CIK 0001982640 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,759.1 Read SEC document |
| June 26, 2023 Filed Jun 28, 2023 23:04 UTC | BIOGEN INC. BIIB · Entity 1675 | GrantCommon Stock | 960 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-23-019545 · form4.xml · nonDerivative · entry 1 LANGER SUSAN · CIK 0001982640 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,419.1 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.